Clinical trial
Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis
NCT00230867 · Transport Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00230867 |
|---|---|
| Title | Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis |
| Official title | A Multicenter, Placebo Controlled, Randomized, Double Blind, Subject Initiated Study of the Safety and Efficacy of a Single Topical Iontophoretic Application of Acyclovir 5% Cream With an Open Label Conventional Therapy Treatment Arm, and a Blinded Evaluator, for the Treatment of Recurrent Herpes… |
| Lead sponsor | Transport Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Herpes Labialis |
| Intervention type | Device |
| Interventions | iontophoretic acyclovir |
| Enrollment | 1,800 |
| Start date | Apr 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Oct 3, 2005 |
| Last update posted | Jul 4, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: